BARRY RING: Open Payments
NPI 1487668695 · HOBART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 23 payments from 11 companies in 2025. Trend: 2023 $743 · 2024 $212 · 2025 $1,250
Travel & lodging: $634Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| SPINEFRONTIER, INC. | 3 | $781 |
| Abbott Laboratories | 1 | $103 |
| Orexo US, Inc. | 5 | $96 |
| ABBVIE INC. | 4 | $88 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: Inspan, PROCLAIM, Zubsolv, UBRELVY, JOURNAVX, RELISTOR, Belbuca, QULIPTA.
Industry payments across IN — which companies pay providers there.
